Partial transfer of holdings in USM HEALTHCARE MEDICAL DEVICES FACTORY JOINT STOCK COMPANY has been completed, and USM is excluded from the consolidated scope. The impact amount post-transfer is still undetermined, and its effect on the December-term consolidated earnings forecast is under review.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7915","jir_company_name":"NISSHA Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/7915-20260917-01.pdf","jir_short_summary":"Partial transfer of holdings in USM HEALTHCARE MEDICAL DEVICES FACTORY JOINT STOCK COMPANY has been completed, and USM is excluded from the consolidated scope. The impact amount post-transfer is still undetermined, and its effect on the December-term consolidated earnings forecast is under review.","jir_summary":"### Background and current status\nNISSHA has completed the partial transfer of shares in its consolidated subsidiary USM, and USM has been excluded from the company\u2019s consolidated scope. The company\u2019s stake after the transfer will be 10%, substantially reduced from 60% prior to the transfer. The transfer price and related details are currently under review, and further disclosure is planned.\n\n### Financial impact and future outlook\nAs a result of this transfer, it is expected that gains or losses on sale of affiliated company shares will be recorded in the individual and consolidated accounts for the fiscal year ending December 2026, but the amounts are not yet determined. The impact on the full-year 2026 consolidated earnings forecast is also under review, and will be announced promptly once finalized. In addition, for shares already transferred, there are plans to potentially conduct additional transfers in mid-September 2027 to mid-September 2028.","jir_financial_highlights":"Number of USM shares transferred: 14,134,064 (Before transfer 16,960,877 shares (60%) \u2192 After transfer 2,826,813 shares (10%))\nCompletion of USM share transfer: Completed (Transfer date: today)\nImpact on full-year 2026 consolidated earnings forecast: Unknown (Under review)","jir_category":"","jir_hashtags":"#NISSHA, #DisclosureProgress, #ConsolidatedSubsidiaryChange","jir_key_figures":"Pre-transfer USM shareholding: 16,960,877 shares (60% of USM shares)\nPost-transfer USM shareholding: 2,826,813 shares (10% of USM shares)\nTransferred shares: 14,134,064 shares (50% of USM shares transferred)","jir_meta_title":"\u3010NISSHA\u3011Notice of Completion of Change in Consolidated Subsidiaries (Share Transfer) | 2026-09-17","jir_meta_description":"NISSHA has transferred part of USM shares and excluded them from consolidation. The transfer amount is undetermined, and the impact on the December-term consolidated performance is under review. Plans for additional transfers are disclosed.","jir_og_title":"NISSHA: Notice of Completion of Consolidated Subsidiary Change","jir_og_description":"Partial transfer of USM shares completed; consolidated status is updated. Financial impact to be determined, with plans for additional transfers disclosed.","jir_og_image_url":"\/assets\/og\/company-disclosure.jpg","jir_chart_data_collection":"[]","ir_related_company":17150,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-115001","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n